Drugs / OD-PHOENIX
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02736318 | Jan 2017 → Sep 2021 | — | TBF Genie Tissulaire | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1/2 | NCT02430558 | Apr 2016 → Jun 2021 | articular cartilage disorder | TBF Genie Tissulaire | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OD-PHOENIX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02736318 ↗ |
| Modality | Other / unclassified | “Decellularized, freeze-dried, irradiated osteochondral allograft” NCT02430558 ↗ |